Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 139.52B | 142.38B | 155.50B | 142.61B | 111.24B | 98.99B |
Gross Profit | 21.83B | 22.89B | 29.69B | 24.57B | 21.99B | 13.58B |
EBITDA | 20.39B | 20.16B | 26.73B | 32.39B | 21.25B | 10.67B |
Net Income | 6.60B | 7.29B | 11.29B | 17.94B | 12.38B | 3.77B |
Balance Sheet | ||||||
Total Assets | 265.39B | 267.73B | 250.89B | 246.93B | 229.53B | 216.66B |
Cash, Cash Equivalents and Short-Term Investments | 21.89B | 21.85B | 17.33B | 22.03B | 21.81B | 18.64B |
Total Debt | 0.00 | 85.50B | 71.55B | 71.56B | 83.73B | 87.58B |
Total Liabilities | 168.90B | 172.73B | 157.97B | 155.64B | 154.40B | 155.14B |
Stockholders Equity | 93.77B | 92.31B | 89.60B | 87.13B | 74.37B | 60.89B |
Cash Flow | ||||||
Free Cash Flow | -4.31B | -4.64B | 6.47B | 14.47B | 9.28B | 7.10B |
Operating Cash Flow | 8.35B | 7.57B | 17.36B | 23.52B | 15.90B | 13.25B |
Investing Cash Flow | -11.55B | -11.37B | -9.55B | -4.77B | -6.39B | -3.64B |
Financing Cash Flow | 6.19B | 5.77B | -6.67B | -17.98B | -6.74B | -8.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $48.75B | 8.84 | 6.06% | 5.24% | -11.92% | -43.64% | |
77 Outperform | €45.34B | 5.35 | 5.01% | 7.13% | -0.19% | -44.09% | |
75 Outperform | $47.28B | 7.09 | 7.24% | 8.76% | -7.14% | -43.43% | |
75 Outperform | €45.34B | 5.48 | 5.01% | 6.90% | -0.19% | -44.09% | |
74 Outperform | $14.65B | 11.37 | 10.07% | 3.41% | -14.83% | 78.73% | |
66 Neutral | €10.62B | 2.05 | 5.51% | ― | ― | ||
57 Neutral | HK$24.98B | 3.78 | -1.97% | 5.91% | -0.17% | -66.83% |